PlainPharmaWatch

CMS Open Payments · Program Year 2024

Averitas Pharma Inc.

Averitas Pharma Inc. reported $3,475,302.62 in payments to 14,332 physicians and teaching hospitals across 15,015 transactions.

See the rankings → How this is sourced
$3.5M
Total payments
15,015
Transactions
14,332
Recipients
+$105.7K
General Payments vs PY2023

Averitas Pharma Inc. reported $3,475,302.62 in payments to 14,332 physicians and teaching hospitals in CMS Open Payments Program Year 2024 - ranking #332 of 1,925 reporting manufacturers (0.0% of all US industry payments), averaging $242.49 per recipient across 7 payment categories. Figures are company-reported under the Physician Payments Sunshine Act; a reported payment is a financial relationship, not evidence of wrongdoing.

Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.

Compiled from official public sources by the editorial team.

The verdict

Averitas Pharma Inc. pairs top-quartile payment volume with an unusually diversified payment pattern across a wide recipient base.

#332
of 1,925 companies
0.0%
of all US industry payments
0.1%
paid to its single top recipient
7
payment categories

Release-over-release change

General Payments changed from PY2023 to PY2024

Averitas Pharma Inc.'s CMS-reported General Payments increased by $105.7K (+7.6%) from PY2023 to PY2024. The comparison uses the same CMS manufacturer-by-payment-category summary for both years and excludes research and ownership or investment records.

CMS source labels for this exact identifier: PY2023: AVERITAS PHARMA INC.PY2024: Averitas Pharma Inc.. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.

Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.

General Payments: PY2023 vs PY2024

Annual CMS-reported totals for this company, not an all-category Open Payments total

PY2023$1.4MPY2024$1.5M
PY2023
$1,396,948.17
PY2024
$1,502,656.53

How Averitas Pharma Inc. ranks nationally

Where this company's total reported payments fall within the full national distribution of all 1,925 companies in CMS Open Payments, not just its nearest peers.

Averitas Pharma Inc.'s total vs. every reporting company

CMS Open Payments, Program Year 2024

$3,475,303 Top 17% higher than 83% of 1,925 reporting companies

$9–$28: 3 reporting companies (0%). Below this entry. $28–$87: 10 reporting companies (1%). Below this entry. $87–$270: 20 reporting companies (1%). Below this entry. $270–$838: 41 reporting companies (2%). Below this entry. $838–$2,603: 76 reporting companies (4%). Below this entry. $2,603–$8,084: 114 reporting companies (6%). Below this entry. $8,084–$25,112: 167 reporting companies (9%). Below this entry. $25,112–$78,003: 249 reporting companies (13%). Below this entry. $78,003–$242,294: 295 reporting companies (15%). Below this entry. $242,294–$752,621: 270 reporting companies (14%). Below this entry. $752,621–$2,337,813: 263 reporting companies (14%). Below this entry. $2,337,813–$7,261,783: 200 reporting companies (10%). This entry sits in this band. $7,261,783–$22,556,757: 133 reporting companies (7%). Above this entry. $22,556,757–$70,066,439: 45 reporting companies (2%). Above this entry. $70,066,439–$217,642,369: 26 reporting companies (1%). Above this entry. $217,642,369–$676,046,922: 13 reporting companies (1%). Above this entry. This company $9 $676,046,922 every reporting company, bucketed by value

Each bar is a progressively wider band; taller bars hold more reporting companies. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Open Payments · 2024

What the Data Shows for Averitas Pharma Inc.

Averitas Pharma Inc. ranks #332 out of 1,925 companies in the CMS Open Payments database for Program Year 2024, a comparatively small 0.0% slice of all industry payments reported nationwide for the year. The underlying total is $3,475,302.62 across 15,015 transactions to 14,332 physicians and teaching hospitals - $231.46 per transaction and $242.49 per recipient on average.

Of the 7 general-payment categories charted below, "Honoraria" is the largest at $641.5K across 341 transactions, 18.5% of the company's reported total (see our methodology for how research and ownership payments are reported separately).

General Payment Breakdown by Type

"Honoraria" leads Averitas Pharma Inc.'s 7-category general-payment breakdown at $641.5K, 18.5% of the reported total.

How Averitas Pharma Inc. divides its payments

General-payment categories, ordered by reported total

1. Honoraria$641.5K2. Food and Beverage$426.0K3. Compensation for Services…$226.9K4. Travel and Lodging$112.1K5. Consulting Fee$80.3K6. Grant$15.5K7. Education$468.75
Payment Type Amount Transactions
Honoraria $641.5K 341
Food and Beverage $426.0K 13,062
Compensation for Services Other Than Consulting $226.9K 142
Travel and Lodging $112.1K 740
Consulting Fee $80.3K 34
Grant $15.5K 1
Education $468.75 12

Recipient Concentration in General Payments

The five largest recipient relationships account for $391,827.90 (26.1%) of $1,502,656.53 in this company's General Payments records across 7,544 recipients. This is a CMS Open Payments Program Year 2024 General Payments view only: it excludes research and ownership/investment records, so it is not the all-category company total above.

Largest General-Payment relationships for Averitas Pharma Inc.

The five named recipients with the highest reported General Payments from this company

Mark H Coleman$83.2KDavid Reece$82.9KMaged Guirguis$75.8KWaleed El-Feky$75.8KAlaa Abd-Elsayed$74.2K
  1. 1

    Mark H Coleman

    $83,159.43 across 143 reported transactions

  2. 2

    David Reece

    $82,881.35 across 128 reported transactions

  3. 3

    Maged Guirguis

    $75,803.95 across 102 reported transactions

  4. 4

    Waleed El-Feky

    $75,771.28 across 148 reported transactions

  5. 5

    Alaa Abd-Elsayed

    $74,211.89 across 80 reported transactions

Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.

Payment Size Analysis

Average transaction size: $231.46. Average per recipient: $242.49.

Total Amount

$3,475,302.62

Avg per Transaction

$231.46

Avg per Recipient

$242.49

Payment Transparency Context

What is the Sunshine Act?

The Physician Payments Sunshine Act (part of the Affordable Care Act) requires pharmaceutical and medical device manufacturers to report payments and transfers of value to physicians and teaching hospitals. These payments can include consulting fees, research grants, speaker fees, food and beverages, travel, royalties, and other forms of compensation.

Industry Total (2024)

$13.9B

across 1,925 companies

Averitas Pharma Inc. Share

0.0%

#332 by total payments

Companies with Similar Payment Volumes

Pharmaceutical companies with payment totals similar to Averitas Pharma Inc.

Puma Biotechnology, Inc.

$3.5M 5,232 recipients

Sumitomo Pharma Co., Ltd.

$3.5M 89 recipients

Acumed LLC

$3.5M 4,053 recipients

Amplify Surgical, Inc.

$3.5M 66 recipients

Kowa Company, Ltd.

$3.5M 0 recipients

Ethicon Inc.

$3.5M 2,774 recipients

Frequently Asked Questions

How much did Averitas Pharma Inc. pay to physicians and hospitals in 2024? ▾
Averitas Pharma Inc. made $3,475,302.62 in payments to physicians and hospitals in Program Year 2024, across 15,015 individual transactions. This represents 0.0% of all industry payments reported to CMS Open Payments.
How many physicians received payments from Averitas Pharma Inc.? ▾
Averitas Pharma Inc. made payments to 14,332 physicians and teaching hospitals in 2024. The average payment per recipient was $242.49.
What types of payments did Averitas Pharma Inc. make? ▾
General payments from Averitas Pharma Inc. span 7 distinct categories, covering things like consulting, meals, and travel. The largest general-payment category was "Honoraria" at $641.5K, representing 18.5% of the company's reported total.
How does Averitas Pharma Inc. rank among pharmaceutical companies? ▾
Averitas Pharma Inc. ranks #332 out of 1,925 companies by total payment amount in the CMS Open Payments database for 2024.
What is the average payment size from Averitas Pharma Inc.? ▾
In 2024, Averitas Pharma Inc. averaged $231.46 per transaction across 15,015 transactions to 14,332 recipients.
Where does the payment data for Averitas Pharma Inc. come from? ▾
This data comes from the CMS Open Payments program (Sunshine Act), which requires pharmaceutical and medical device companies to report payments and transfers of value to physicians and teaching hospitals. The data covers Program Year 2024.

Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. Total industry payments: $13.9B across 1,925 companies.

Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch Editorial
Disclaimer

This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

View saved (companies)
Download Averitas Pharma Inc.'s data (CSV)
Embed this widget

Copy this snippet to embed a live-linked card on your own site.

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-25.